Athersys

RW Mays, Ph.D., Vice President of Regenerative Medicine 

Oct. 11 | 4:00pm | Oxford Biomedica Ballroom 

Cleveland, OH 

(NASDAQ: ATHX) 

In-person Presentation 

Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life. Our focus is on the treatment of medical conditions where there is significant clinical need, and we are particularly focused on developing therapies in the regenerative medicine area. We are developing MultiStem®, a patented, adult-derived off-the-shelf stem cell therapy platform, for disease indications in areas of neurological, inflammatory and immune, and cardiovascular disease areas, as well as other critical care indications where there is substantial unmet medical need due to the limitations in standard of care. 

www.athersys.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions